Karel Mena Ulecia PhD: Associate Professor in the Department of Biological and Chemical Sciences at the Catholic University of Temuco. He completed his doctoral studies in Molecular Physical Chemistry at the Andres Bello University with the highest distinction. In the last 5 years, he has been the principal investigator of two projects based on the design of antihypertensive drugs and the mechanism of resistance to antibacterial drugs. He has published 15 articles in different journals over the last 5 years. A considerable part of the work and collaborations carried out by Professor Karel Mena-Ulecia is the application of computational methodologies to study molecular systems of biological origin. An innovative contribution of his work is to establish new perspectives about the interactions between several drugs and proteins, combining bioinformatics tools (molecular docking, QSAR, molecular dynamics simulations, and free energy calculations). We are currently applying these tools to contribute to the design of new drugs against various diseases.
Karel Mena Ulecia PhD: Associate Professor in the Department of Biological and Chemical Sciences at the Catholic University of Temuco. He completed his doctoral studies in Molecular Physical Chemistry at the Andres Bello University with the highest distinction. In the last 5 years, he has been the principal investigator of two projects based on the design of antihypertensive drugs and the mechanism of resistance to antibacterial drugs. He has published 15 articles in different journals over the last 5 years. A considerable part of the work and collaborations carried out by Professor Karel Mena-Ulecia is the application of computational methodologies to study molecular systems of biological origin. An innovative contribution of his work is to establish new perspectives about the interactions between several drugs and proteins, combining bioinformatics tools (molecular docking, QSAR, molecular dynamics simulations, and free energy calculations). We are currently applying these tools to contribute to the design of new drugs against various diseases.